据意大利研究人员称,接受于细胞移植并且达到分子临床缓解效果的多发性骨髓瘤患者与疾病长期保持在分子水平的患者相比,具有更长的疾病控制期和更低的复发率。意大利波伦亚大学的Giovanni Martinelli及其同事对施行过同种移植或自身移 According to Italian researchers, patients with multiple myeloma who have undergone cell transplantation and achieved molecular clinical remission have a longer period of disease control and a lower rate of recurrence than patients with long-term molecular disease. Giovanni Martinelli and his colleagues from the University of Bologna, Italy, have performed the same kind of transplant or moved themselves